These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6412997)

  • 1. [Neonatal thrombopenia caused by antiPLA1 and HLA-DR3 antigen alloimmunization].
    Muller JY; Reznikoff-Etievant MF; Patereau C; Julien F
    C R Seances Acad Sci III; 1983; 296(20):953-6. PubMed ID: 6412997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloimmunization against the platelet-specific Zwa antigen, resulting in neonatal alloimmune thrombocytopenia or posttransfusion purpura, is associated with the supertypic DRw52 antigen including DR3 and DRw6.
    de Waal LP; van Dalen CM; Engelfriet CP; von dem Borne AE
    Hum Immunol; 1986 Sep; 17(1):45-53. PubMed ID: 3488986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmunization to the PlA1 platelet antigen: results of a prospective study.
    Blanchette VS; Chen L; de Friedberg ZS; Hogan VA; Trudel E; Décary F
    Br J Haematol; 1990 Feb; 74(2):209-15. PubMed ID: 2317456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3.
    Mueller-Eckhardt C; Mueller-Eckhardt G; Willen-Ohff H; Horz A; Küenzlen E; O'Neill GJ; Schendel DJ
    Tissue Antigens; 1985 Jul; 26(1):71-6. PubMed ID: 3929422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isoimmune neonatal thrombopenia caused by anti-PLA1 antibodies. Apropos of 2 cases].
    Loza J; Renovales A; Ribera A; Atucha L; Martín C; Pérez Clausell C
    Sangre (Barc); 1984; 29(3):310-3. PubMed ID: 6548321
    [No Abstract]   [Full Text] [Related]  

  • 6. Is HLA-DR3 a risk factor in PLA1-negative pregnant women?
    Décary F
    Curr Stud Hematol Blood Transfus; 1986; (52):78-86. PubMed ID: 3486096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunization against the ZWa (PLA1) platelet antigen: group at risk, prevention of complications. Apropos of 132 cases].
    Reznikoff-Etievant MF; Muller JY; Kaplan C; Patereau C; Clémenceau S; Simonney N; Castellano F; Daffos F; Forestier F; Poissonnier MH
    Pathol Biol (Paris); 1986 Jun; 34(6):783-7. PubMed ID: 3531996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen.
    Valentin N; Vergracht A; Bignon JD; Cheneau ML; Blanchard D; Kaplan C; Reznikoff-Etievant MF; Muller JY
    Hum Immunol; 1990 Feb; 27(2):73-9. PubMed ID: 2298610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal alloimmune thrombocytopenia. Case reports, diagnostic and therapeutic considerations.
    Brockmeier FK; Nordhagen R; Finne PH
    Acta Paediatr Scand; 1983 Jul; 72(4):583-7. PubMed ID: 6353848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HLA-DR3 subtypes associated with immunization against HLA-1a antigen in families with alloimmune neonatal thrombopenia].
    Choukri F
    Transfus Clin Biol; 1995; 2(3):151-8. PubMed ID: 7542983
    [No Abstract]   [Full Text] [Related]  

  • 11. A second case of neonatal alloimmune thrombocytopenia associated with anti-PlA2 (Zwb) antibodies.
    Maslanka K; Lucas GF; Gronkowska A; Davis JG; Zupanska B
    Haematologia (Budap); 1989; 22(2):109-13. PubMed ID: 2744637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet anti-Bakb antibody associated with neonatal alloimmune thrombocytopenia.
    McGrath K; Minchinton R; Cunningham I; Ayberk H
    Vox Sang; 1989; 57(3):182-4. PubMed ID: 2617952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neonatal alloimmune thrombopenia. Clinical and biological study of 84 cases].
    Muller JY; Reznikoff-Etievant MF; Patereau C; Dangu C; Chesnel N
    Presse Med; 1985 Jan; 14(2):83-6. PubMed ID: 3156330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allo-immune thrombocytopenias, definition of a group at risk; a prospective study.
    Reznikoff-Etievant MF; Kaplan C; Muller JY; Daffos F; Forestier F
    Curr Stud Hematol Blood Transfus; 1988; (55):119-24. PubMed ID: 3365995
    [No Abstract]   [Full Text] [Related]  

  • 15. Brb, a platelet alloantigen involved in neonatal alloimmune thrombocytopenia.
    Bettaieb A; Fromont P; Rodet M; Godeau B; Duedari N; Bierling P
    Vox Sang; 1991; 60(4):230-4. PubMed ID: 1926830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal thrombopenia caused by antiplatelet alloimmunization. Management].
    Reznikoff-Etievant MF; Lobet R; Julien F
    Presse Med; 1983 Feb; 12(9):575. PubMed ID: 6219374
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal alloimmune thrombocytopenia: a clinical perspective.
    Blanchette VS
    Curr Stud Hematol Blood Transfus; 1988; (54):112-26. PubMed ID: 3280252
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alloimmune thrombocytopenia in newborn infants caused by specific anti-platelet antibodies].
    Maślanka K
    Pediatr Pol; 1985 Jan; 60(1):69-75. PubMed ID: 3162148
    [No Abstract]   [Full Text] [Related]  

  • 19. Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-Antibody specificity analysis using epitope data.
    Dahl J; Refsum E; Ahlen MT; Egeland T; Jensen T; Viken MK; Stuge TB; Acharya G; Husebekk A; Skogen B; Tiller H
    J Reprod Immunol; 2017 Aug; 122():1-9. PubMed ID: 28686909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRa (HPA-5b) incompatibility may cause thrombocytopenia in neonates of mothers with immune thrombocytopenic purpura.
    Gururangan S; McFarland JG; Cines DB; Skupski D; Bussel JB
    J Pediatr Hematol Oncol; 1998; 20(3):202-6. PubMed ID: 9628430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.